Advanced search

Instruments

Name		Stock exchange	Average volume	Price	Type
PT PAM MINERAL TBK	NICL	INDONESIA S.E.	24,171,847	143 IDR	Stock
CHENG LOONG CORPORATION	1904	Taiwan S.E.	786,900	29 TWD	Stock
TIAN CHENG HOLDINGS LIMITED	2110	Hong Kong S.E.	43,214	0.185 HKD	Stock
C CHENG HOLDINGS LIMITED	1486	Hong Kong S.E.	-	0.455 HKD	Stock
CHENG MEI MATERIALS TECHNOLOGY CORPORATION	4960	Taiwan S.E.	9,582,202	14.65 TWD	Stock
CHENG DE LOLO COMPANY LIMITED	000848	Shenzhen S.E.	13,301,123	9.28 CNY	Stock
YUAN CHENG CABLE CO.,LTD.	002692	Shenzhen S.E.	9,033,930	4.09 CNY	Stock
LI CHENG ENTERPRISE CO., LTD.	4426	Taiwan S.E.	256,007	17.2 TWD	Stock
CHI CHENG ENTERPRISE CO., LTD.	3095	Taipei Exchange	117,287	35.1 TWD	Stock
CHENG FWA INDUSTRIAL CO., LTD.	5426	Taipei Exchange	1,789,776	32.55 TWD	Stock

See all

News (86)

Transcript : AXT, Inc., Q1 2024 Earnings Call, May 02, 2024	05-02
LTC Properties : SUPPLEMENTAL OPERATING AND FINANCIAL DATA Q1 2024	04-29	PU
AstraZeneca : 2023 Sustainability Highlights presentation	03-22	PU
Transcript : AstraZeneca PLC - Special Call	03-22
AstraZeneca to boost cell therapy operations with $300m manufacturing investment	02-07	AQ
AstraZeneca expands US manufacturing footprint to accelerate ambitions in next-generation cell therapy discovery and development	02-06	BU
Smiths Group plc Announces Directors' Change in Responsibilities	01-24	CI
AstraZeneca to leverage its global industrial-scale manufacturing and digital capabilities to boost US renewable natural gas productivity	11-08	BU
LTC Properties : Supplemental Operating & Financial Data	23-10-26	PU
Smiths : 2023 Notice of Annual General Meeting	23-10-12	PU
AstraZeneca announces innovative partnership with Vanguard Renewables to decarbonize its United States sites	23-06-13	BU
AstraZeneca : 2022 Sustainability Highlights presentation	23-03-23	PU
LTC Properties : Q4 2022 Supplemental Operating and Financial Data	23-02-18	PU
Smiths : 2022 Annual General Meeting Voting Results	22-11-16	PU
Smiths : Notice of AGM	22-10-13	PU
Transcript : AstraZeneca PLC, Q1 2022 Earnings Call, Apr 29, 2022	22-04-29
Model N Completes Rainmaker22: Largest Virtual Conference Reporting on the Outlook for Revenue Optimization and Compliance	22-03-31	BU
LTC Properties : Q4 2021 Supplemental Operating and Financial Data-Amended	22-02-18	PU
LTC Properties : Q4 2021 Supplemental Operating and Financial Data	22-02-17	PU
Samsung Biologics and AstraZeneca expand strategic manufacturing partnership to include COVID-19 and cancer therapy	21-12-13	PR
Smiths : 2021 Annual General Meeting Voting Results	21-11-17	PU
Smiths : 2021 Notice of Annual General Meeting	21-11-15	PU
Q3 2021 Supplemental Operating and Financial Data	21-10-28	PU
AstraZeneca : Investment will transform development and commercialisation of new medicines (Form 6-K)	21-09-21	PU
AstraZeneca to invest $360 million in Irish drug manufacturing site	21-09-21	RE
AstraZeneca : to invest $360m in advanced manufacturing facility in Ireland	21-09-21	PU
LTC Properties : Q2 2021 Supplemental Operating and Financial Data	21-07-29	PU
Transcript : LTC Properties, Inc. - Shareholder/Analyst Call	21-05-26
Imperva® to Acquire CloudVector, Accelerates Vision for Web Application and API Protection	21-05-03	BU
Transcript : LTC Properties, Inc., Q1 2021 Earnings Call, Apr 30, 2021	21-04-30
Transcript : AstraZeneca PLC, Q1 2021 Earnings Call, Apr 30, 2021	21-04-30
LTC Properties : Transcript of LTC Properties, Inc. Q1 2021 Earnings Call	21-04-29	PU
Mountain Commerce Bancorp : Bank Announces Promotions for Ten Key TriCities Team Members	21-03-14	PU
AstraZeneca : Vaccine production not perfect but our drug saves lives, AstraZeneca says, as Africa backs COVID-19 shot	21-02-12	RE
Vaccine production not perfect but our drug saves lives, AstraZeneca says, as Africa backs COVID-19 shot	21-02-12	RE
Transcript : AstraZeneca PLC, Q4 2020 Earnings Call, Feb 11, 2021	21-02-11
AstraZeneca : Gears Up to Vaccinate the World Against Covid-19	20-11-24	DJ
AstraZeneca : Encouraging Oxford vaccine results keep Britain on track for spring roll-out	20-11-23	RE
Instant View: AstraZeneca says its coronavirus vaccine can be around 90% effective	20-11-23	RE
Instant view: AstraZeneca says its coronavirus vaccine can be around 90% effective	20-11-23	RE
AstraZeneca will have enough COVID-19 vaccine for 200 million doses this year	20-11-23	RE
Smiths : 2020 Annual General Meeting Presentation	20-11-17	PU
Smiths : 2020 Annual General Meeting Voting Results	20-11-17	PU
Transcript : AstraZeneca PLC, Q3 2020 Earnings Call, Nov 05, 2020	20-11-05
Medtronic : Biennial 2020 Investor & Analyst Meeting - Citations	20-10-15	PU

123NextSee all

Companies (34)

CC INTERNATIONAL 35 M $

CC International Berhad is a Malaysia-based investment holding company. The Companyâs subsidiaries include Cheng & Co Taxation Sdn. Bhd., Pro B Centre Sdn. Bhd., Cheng & Co Global Advisory Sdn. Bhd., Cheng & Co Wealth Management Sdn. Bhd., Cheng & Co Ri ...

WIRELESS POWER AMPLIFIER MODULE INC. 98 M $

Wireless Power Amplifier Module Inc is a Korea-based company engaged in the manufacture and sale of power amplifier modules (PAMs) to mobile communication systems. The Company's main products include multi mode multi band power amplifier modules (MMMB PAM ...

CHENG DE LOLO COMPANY LIMITED 1 317 M $

CHENG DE LOLO Co Ltd, formerly He Bei Cheng De LoLo Co Ltd, is a China-based company mainly engaged in the production and sales of vegetable protein beverages. The Company mainly sells almond milk drinks under the brand LoLo. The Company's products includ ...

ADDEX THERAPEUTICS LTD 10 M $

Addex Therapeutics Ltd is a Switzerland-based clinical-stage pharmaceutical company. The Company focuses on development and commercialization of orally available small molecule drugs known as allosteric modulators for neurological disorders. The Companyâ ...

TELADAN SETIA GROUP 179 M $

Teladan Group Berhad, formerly Teladan Setia Group Berhad, is a Malaysia-based company, which is engaged in property development. The Company is focused on developing both residential and commercial properties. It has property developments in Melaka. It h ...

LI CHENG ENTERPRISE CO., LTD. 92 M $

LI CHENG ENTERPRISE CO., LTD. is a Taiwan-based company principally engaged in the research, development, production and sales of knitted fabrics. The Company's main products include knitted mesh, pan yarns and raw materials. The Company is also involved ...

C CHENG HOLDINGS LIMITED 17 M $

C Cheng Holdings Limited is a Hong Kong-based investment holding company principally engaged in the provision of comprehensive architectural services. Its businesses mainly include architecture design, landscape architecture design, town planning, interio ...

EMBRY HOLDINGS LIMITED 19 M $

Embry Holdings Limited is a Hong Kong-based investment holding company principally engaged in the manufacture and sales of lingerie for women. Its primary products include brassieres, panties, girdles and corsets, swimwear, aerobics wear, sleepwear, panty ...

WAN CHENG METAL PACKAGING COMPANY LIMITED 2 M $

Wan Cheng Metal Packaging Company Limited is an investment holding company. The Company and its subsidiaries are principally engaged in manufacturing and sales of tinplate packaging products in the Peopleâs Republic of China. Through its subsidiaries, t ...

CHENG FWA INDUSTRIAL CO., LTD. 144 M $

Cheng Fwa Industrial Co., Ltd. is a Taiwan-based company principally engaged in the manufacture, processing and sales of video decoder casings and related components. The Company is also engaged in the manufacture and sales of computer casings and related ...

1234Next

Insiders

Pam Cheng

Pam P. Cheng occupies the position of Executive VP-Operations & Information Technology at AstraZeneca Plc. Ms. Cheng is also on the board of Smiths Group Plc. She previously held the position of Senior VP-Global Supply Chain Management at Merck & Co., Inc. and President of MSD China Holding Co., Ltd. (a subsidiary of Merck & Co., Inc.). Ms. Cheng received an MBA from Pace University and a graduate degree and an undergraduate degree from Stevens Institute of Technology.

No results for this search